Would pan-tuberculosis treatment regimens be cost-effective?

Emily A. Kendall; Grania Brigden; Christian Lienhardt; David W. Dowdy

doi:10.1016/S2213-2600(18)30197-8

Would pan-tuberculosis treatment regimens be cost-effective?

Emily A. Kendall, Grania Brigden, Christian Lienhardt, David W. Dowdy

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	486-488
Number of pages	3
Journal	The Lancet Respiratory Medicine
Volume	6
Issue number	7
DOIs	https://doi.org/10.1016/S2213-2600(18)30197-8
State	Published - Jul 2018

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1016/S2213-2600(18)30197-8

Cite this

@article{cf27de7157fd43189a2832cc06f26e7f,

title = "Would pan-tuberculosis treatment regimens be cost-effective?",

author = "Kendall, {Emily A.} and Grania Brigden and Christian Lienhardt and Dowdy, {David W.}",

note = "Funding Information: We declare no competing interests. EAK was supported by the National Institution of Allergy and Infectious Diseases of the National Institutes of Health under award number K08AI127908.",

year = "2018",

month = jul,

doi = "10.1016/S2213-2600(18)30197-8",

language = "English (US)",

volume = "6",

pages = "486--488",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",